Korea Investment CORP Cuts Stake in Johnson & Johnson

The institutional investor reduced its position in the healthcare giant by 13.5% in the third quarter.

Mar. 8, 2026 at 11:50am

Got story updates? Submit your updates here. ›

Korea Investment CORP, a major institutional investor, has reduced its stake in Johnson & Johnson (NYSE:JNJ) by 13.5% in the third quarter, according to a recent filing with the Securities and Exchange Commission. The investor now holds 1,585,942 shares of the company's stock, valued at approximately $294 million.

Why it matters

Johnson & Johnson is a bellwether stock in the healthcare sector, and changes in major institutional holdings can signal broader market sentiment. This reduction in Korea Investment CORP's position could indicate a shift in investor outlook on the company or the sector as a whole.

The details

According to the filing, Korea Investment CORP sold 247,334 shares of Johnson & Johnson during the third quarter, reducing its total position to 1,585,942 shares. The investor's stake in the company now represents approximately 0.6% of its overall portfolio.

  • Korea Investment CORP filed the disclosure in the third quarter of 2026.

The players

Korea Investment CORP

A major institutional investor that manages a diversified portfolio of assets.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals, medical devices, and consumer health.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Korea Investment CORP's position in Johnson & Johnson could signal a broader shift in investor sentiment towards the healthcare sector, though the specific reasons behind the move are not yet clear. Investors will likely continue to monitor institutional holdings and market trends in the coming quarters to gauge the overall outlook for Johnson & Johnson and the healthcare industry.